Friday | 25 July, 2008
Australian Biotechnology News

News

  • +

    Keep it on, HIV+ people warned 25/07/2008 13:09:21

    Australian researchers urge HIV-positive people on antiretrovirals to continue practising safe sex
    Australian researchers urge HIV-positive people on antiretrovirals to continue practising safe sex
  • +

    The gene, the clinic and the sex life of the dung beetle 25/07/2008 13:14:35

    The July/August 2008 issue of Australian Life Scientist is out now.
    The July/August 2008 issue of Australian Life Scientist is out now.
  • +

    Opinion: Cash, not coddling, needed from Carr 25/07/2008 13:12:25

    The biotechnology sector in Australia is fuming at the Federal Government, according to the editorial in the latest issue of ALS
    The biotechnology sector in Australia is fuming at the Federal Government, according to the editorial in the latest issue of ALS
  • +

    Combination therapy for HIV 25/07/2008 16:31:51

    Merck drug raltegravir shows good results as part of combination therapy
    Merck drug raltegravir shows good results as part of combination therapy
  • +

    IP Australia sits US exams 25/07/2008 16:49:04

    IP Australia named as search and examination authority for US patent office
    IP Australia named as search and examination authority for US patent office
  • +

    Cash for medical research support 25/07/2008 16:19:07

    The NHMRC has announced $29 million for medical research institute support services
    The NHMRC has announced $29 million for medical research institute support services
  • +

    Eye and ear on bionics 24/07/2008 14:41:16

    Centre for bionics for NSW, international conference for Victoria
    Centre for bionics for NSW, international conference for Victoria
  • +

    GTG responds to BRCA row 24/07/2008 13:36:01

    Genetic Technologies responds to criticism over patent enforcement decision
    Genetic Technologies responds to criticism over patent enforcement decision
  • +

    More for AtCor 24/07/2008 14:27:04

    AtCor wins two more supply contracts for SphygmoCor, worth $1.66M
    AtCor wins two more supply contracts for SphygmoCor, worth $1.66M
  • +

    Suspect protein promotes DNA repair 24/07/2008 15:29:26

    Caution against targeting HMGB1 protein in inflammation drug development
    Caution against targeting HMGB1 protein in inflammation drug development
  • +

    Flu's up for Rockeby 24/07/2008 15:28:01

    Rockeby receives $252,000 worth of orders for bird flu test
    Rockeby receives $252,000 worth of orders for bird flu test
  • +

    Progen abandons PI-88 23/07/2008 14:43:49

    Massive share price plunge as Progen abandons lead compound trial
    Massive share price plunge as Progen abandons lead compound trial
  • +

    Anadis begins trials for IBD 23/07/2008 15:33:13

    Israeli trial due for completion in 2009, commercialisation as nutritional to follow
    Israeli trial due for completion in 2009, commercialisation as nutritional to follow
  • +

    Pfizer Fellowships close soon 23/07/2008 12:40:24

    Applications for the Pfizer Australia Research Fellowships close on Monday
    Applications for the Pfizer Australia Research Fellowships close on Monday
  • +

    Freeze my puppies 23/07/2008 15:40:20

    Genetic Technologies acquires Frozen Puppies Dot Com
    Genetic Technologies acquires Frozen Puppies Dot Com
Additional Resources

Newsletter Subscription

Sign up for our Australian Life Scientist newsletters!
The latest, most important headlines from Australia and around the world.
A daily e-mail from Australian Biotechnology News, with the latest, most important headlines from Australia and around the world.

Australian Life Scientist Member Login

 
Sponsored Links